Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases

References

• CalvielloGSuHMWeylandtKHFasanoESeriniSCittadiniAExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesBiomed Res Int2013201374317110.1155/2013/74317123691510
   PubMedGoogle Scholar
• MarventanoSKolaczPCastellanoSA review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?Int J Food Sci Nutr201566661162210.3109/09637486.2015.107779026307560
   PubMed Web of Science ®Google Scholar
• DyallSCLong-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHAFront Aging Neurosci201575210.3389/fnagi.2015.0005225954194
   PubMed Web of Science ®Google Scholar
• KitessaSMAbeywardenaMWijesunderaCNicholsPDDHA-containing oilseed: a timely solution for the sustainability issues surrounding fish oil sources of the health-benefitting long-chain omega-3 oilsNutrients2014652035205810.3390/nu605203524858407
   PubMed Web of Science ®Google Scholar
• Bushkin-BedientSCarpenterDOBenefits versus risks associated with consumption of fish and other seafoodRev Environ Health201025316119121038755
   PubMedGoogle Scholar
• NicholsPDMcManusAKrailKSinclairAJMillerMRecent advances in omega-3: health benefits, sources, products and bioavailabilityNutrients2014693727373310.3390/nu609372725255830
   PubMedGoogle Scholar
• WellsMLPotinPCraigieJSAlgae as nutritional and functional food sources: revisiting our understandingJ Appl Phycol201729294998210.1007/s10811-016-0974-528458464
   PubMed Web of Science ®Google Scholar
• MillerMRNicholsPDCarterCGn-3 Oil sources for use in aquaculture–alternatives to the unsustainable harvest of wild fishNutr Res Rev2008212859610.1017/S095442240810241419087364
   PubMed Web of Science ®Google Scholar
• Lenihan-GeelsGBishopKSFergusonLRAlternative sources of omega-3 fats: can we find a sustainable substitute for fish?Nutrients2013541301131510.3390/nu504130123598439
   PubMed Web of Science ®Google Scholar
• MartinsDACustódioLBarreiraLAlternative sources of n-3 long-chain polyunsaturated fatty acids in marine microalgaeMar Drugs20131172259228110.3390/md1107225923807546
   PubMed Web of Science ®Google Scholar
• SpragueMBetancorMBTocherDRMicrobial and genetically engineered oils as replacements for fish oil in aquaculture feedsBiotechnol Lett201739111599160910.1007/s10529-017-2402-628721583
   PubMedGoogle Scholar
• ReynoldsLMulikRSWenXDilipACorbinIRLow-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cellsNanomedicine (Lond)20149142123214110.2217/nnm.13.18724397600
   PubMedGoogle Scholar
• KannoSKurauchiKTomizawaAYomogidaSIshikawaMAlbumin modulates docosahexaenoic acid-induced cytotoxicity in human hepa-tocellular carcinoma cell linesToxicol Lett2011200315416110.1016/j.toxlet.2010.11.00921108996
   PubMedGoogle Scholar
• NamaniTIshikawaTMorigakiKWaldePVesicles from docosahexaenoic acidColloids Surf B Biointerfaces200754111812310.1016/j.colsurfb.2006.05.02216829059
   PubMedGoogle Scholar
• CalderPCThe role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stabilityMol Nutr Food Res20125671073108010.1002/mnfr.20110071022760980
   PubMed Web of Science ®Google Scholar
• InnesJKCalderPCThe differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiometabolic risk factors: a systematic reviewInt J Mol Sci2018192E53210.3390/ijms1902053229425187
   PubMed Web of Science ®Google Scholar
• DeshpandeDJaneroDRAmijiMEngineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human vascular endothelial and smooth muscle cellsNanomedicine20139788589410.1016/j.nano.2013.02.00723473744
   PubMedGoogle Scholar
• DeshpandeDKethireddySJaneroDRAmijiMMTherapeutic effi-cacy of an ω-3-fatty acid-containing 17-β estradiol nano-delivery system against experimental atherosclerosisPLoS One2016112e014733710.1371/journal.pone.014733726840601
   PubMedGoogle Scholar
• SerhanCNPro-resolving lipid mediators are leads for resolution physiologyNature201451075039210110.1038/nature1347924899309
   PubMed Web of Science ®Google Scholar
• SansburyBESpiteMResolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biologyCirc Res2016119111313010.1161/CIRCRESAHA.116.30730827340271
   PubMed Web of Science ®Google Scholar
• CongBXuYShengHCardioprotection of 17β-estradiol against hypoxia/reoxygenation in cardiomyocytes is partly through up-regulation of CRH receptor type 2Mol Cell Endocrinol20143821172510.1016/j.mce.2013.09.00224035863
   PubMedGoogle Scholar
• BorodziczSCzarzastaKKuchMCudnoch-JedrzejewskaASphingolipids in cardiovascular diseases and metabolic disordersLipids Health Dis2015145510.1186/s12944-015-0053-y26076974
   PubMedGoogle Scholar
• BoweyKTanguayJFTabrizianM2-Dioleoyl-sn-glycero-3-phosphocholine-based nanoliposomes as an effective delivery platform for 17β-estradiolEur J Pharm Biopharm201486336937510.1016/j.ejpb.2013.10.00624161656
   PubMedGoogle Scholar
• StoverTCSharmaARobertsonGPKesterMSystemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinomaClin Cancer Res20051193465347410.1158/1078-0432.CCR-04-177015867249
   PubMed Web of Science ®Google Scholar
• BourassaPAMilosPMGaynorBJBreslowJLAielloRJEstrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient miceProc Natl Acad Sci U S A19969310022100278816744
   PubMed Web of Science ®Google Scholar
• SuHLiuRChangMHuangJJinQWangXEffect of dietary alpha-linolenic acid on blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trialsEur J Nutr201857387789110.1007/s00394-017-1386-228275869
   PubMed Web of Science ®Google Scholar
• OuWMulikRSAnwarAMcDonaldJGHeXCorbinIRLow-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinomaFree Radic Biol Med201711259760710.1016/j.freeradbiomed.2017.09.00228893626
   PubMed Web of Science ®Google Scholar
• MossLRMulikRSVan TreurenTKimSYCorbinIRInvestigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cellsBiochim Biophys Acta2016186011 Pt A2363237610.1016/j.bbagen.2016.07.00427418237
   PubMedGoogle Scholar
• WenXReynoldsLMulikRSHepatic arterial infusion of low-density lipoprotein docosahexaenoic acid nanoparticles selectively disrupts redox balance in hepatoma cells and reduces growth of ortho-topic liver tumors in ratsGastroenterology2016150248849810.1053/j.gastro.2015.10.00826484708
   PubMed Web of Science ®Google Scholar
• MulikRSBingCLadouceur-WodzakMMunaweeraIChopraRCorbinIRLocalized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasoundBiomaterials20168325726810.1016/j.biomaterials.2016.01.02126790145
   PubMed Web of Science ®Google Scholar
• GottoAMJrPownallHJHavelRJIntroduction to the plasma lipoproteinsMethods Enzymol19861283413523141
   PubMed Web of Science ®Google Scholar
• FavreGTargeting of tumor cells by low density lipoproteins: principle and use of ellipticin derivativesC R Seances Soc Biol Fil19921861–273871450992
   PubMedGoogle Scholar
• GalDOhashiMMacDonaldPCBuchsbaumHJSimpsonERLow-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasmsAm J Obstet Gynecol198113988778857223790
   PubMed Web of Science ®Google Scholar
• HoYKSmithRGBrownMSGoldsteinJLLow-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cellsBlood197852610991114214187
   PubMed Web of Science ®Google Scholar
• CasarilMCorsoFBassiADecreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastasesInt J Clin Lab Res199424294977919435
   PubMedGoogle Scholar
• YangLYChenWLLinJWDifferential expression of antioxidant enzymes in various hepatocellular carcinoma cell linesJ Cell Biochem20059662263110.1002/jcb.2054116052474
   PubMedGoogle Scholar
• MerendinoNLoppiBD’AquinoMDocosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidationNutr Cancer20055222523310.1207/s15327914nc5202_1216201853
   PubMed Web of Science ®Google Scholar
• BertrandRLIron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying eventsMed Hypotheses2017101697410.1016/j.mehy.2017.02.01728351498
   PubMed Web of Science ®Google Scholar
• SeriniSPiccioniEMerendinoNCalvielloGDietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancerApoptosis200914213515210.1007/s10495-008-0298-219130233
   PubMed Web of Science ®Google Scholar
• SchwenkRWHollowayGPLuikenJJFPBonenAGlatzJFCFatty acid transport across the cell membrane: regulation by fatty acid transportersProstaglandins Leukot Essent Fatty Acids2010824–614915410.1016/j.plefa.2010.02.02920206486
   PubMed Web of Science ®Google Scholar
• KhanAAAlanaziAMJabeenMHassanIBhatMATargeted nano-delivery of novel omega-3 conjugate against hepatocellular carcinoma: regulating COX-2/bcl-2 expression in an animal modelBiomed Pharmacother20168139440110.1016/j.biopha.2016.04.03327261618
   PubMed Web of Science ®Google Scholar
• KhanAAAlamMTufailSMustafaJOwaisMSynthesis and characterization of novel PUFA esters exhibiting potential anticancer activities: an in vitro studyEur J Med Chem201146104878488610.1016/j.ejmech.2011.07.04421868138
   PubMed Web of Science ®Google Scholar
• AltenburgJDHarveyKAMcCraySXuZSiddiquiRAA novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell linesBiochem Biophys Res Commun2011411242743210.1016/j.bbrc.2011.06.17221749860
   PubMedGoogle Scholar
• SiemionIZKluczykATuftsin: on the 30-year anniversary of Victor Najjar’s discoveryPeptides199920564567410465518
   PubMedGoogle Scholar
• KhanMAAljarbouAKhanAOwaisMImmune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C miceFEMS Immunol Med Microbiol2012661889710.1111/j.1574-695X.2012.00992.x22612788
   PubMedGoogle Scholar
• KhanAKhanAADwivediVAhmadMGHakeemSOwaisMTuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino miceMol Med2007135–626627610.2119/2007-00018.Khan17622310
   PubMed Web of Science ®Google Scholar
• BaiKBLángOOrbánEDesign, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexateBioconjug Chem200819112260226910.1021/bc800115w18959436
   PubMed Web of Science ®Google Scholar
• HalderRCAlmasiASagongBLeungJJewettAFialaMCurcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ productionFront Physiol2015612910.3389/fphys.2015.0009826052286
   PubMedGoogle Scholar
• SongMNishiharaRCaoYMarine ω-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T cellsJAMA Oncol2016291197120610.1001/jamaoncol.2016.060527148825
   PubMedGoogle Scholar
• RoyJOliveiraLTOgerCPolymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferationJ Exp Clin Cancer Res20153415510.1186/s13046-015-0273-z26689718
   PubMed Web of Science ®Google Scholar
• LeiteEAGrabe-GuimarãesAGuimarãesHNMachado-CoelhoGLLBarrattGMosqueiraVCFCardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devicesLife Sci200780141327133410.1016/j.lfs.2006.12.01917303179
   PubMedGoogle Scholar
• SchleyPDJijonHBRobinsonLEFieldCJMechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cellsBreast Cancer Res Treat200592218719510.1007/s10549-005-2415-z15986129
   PubMedGoogle Scholar
• RogersKRKikawaKDMouradianMDocosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft associationCarcinogenesis20103191523153010.1093/carcin/bgq11120525880
   PubMedGoogle Scholar
• ChauvinLGoupilleCBlancCLong chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathwaysBiochim Biophys Acta20161861438039010.1016/j.bbalip.2016.01.01226821209
   PubMed Web of Science ®Google Scholar
• SatoSBParkJKawamotoJSatoSKuriharaTInhibition of constitutive Akt (PKB) phosphorylation by docosahexaenoic acid in the human breast cancer cell line MDA-MB-453Biochim Biophys Acta20131831230631310.1016/j.bbalip.2012.10.00423085420
   PubMedGoogle Scholar
• LeeEJYunUJKooKHDown-regulation of lipid raft-associated oncoproteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosisBiochim Biophys Acta20141841119020310.1016/j.bbalip.2013.10.00624120917
   PubMedGoogle Scholar
• SeriniSCalvielloGModulation of Ras/ERK and phosphoinositide signaling by Long-Chain n-3 PUFA in breast cancer and their potential complementary role in combination with targeted drugsNutrients201793E18510.3390/nu903018528241486
   PubMedGoogle Scholar
• AlaargAJordanNYVerhoefJJMetselaarJMStormGKokRJDocosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessmentInt J Nanomedicine2016115027504010.2147/IJN.S11599527785012
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHBarenholzYPharmacokinetics of PEGylated liposomal doxorubicin: review of animal and human studiesClin Pharmacokinet200342541943610.2165/00003088-200342050-0000212739982
   PubMed Web of Science ®Google Scholar
• SkibinskiCGDasAChenKMA novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell linesChem Biol Interact20162521810.1016/j.cbi.2016.03.03527041074
   PubMedGoogle Scholar
• ClarkASWestKStreicherSDennisPAConstitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cellsMol Cancer Ther20021970771712479367
   PubMed Web of Science ®Google Scholar
• SeriniSOttes VasconcelosRFasanoECalvielloGHow plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?Nutr Res Rev201629110212510.1017/S095442241600004427172872
   PubMed Web of Science ®Google Scholar
• VaidyaTStraubingerRMAit-OudhiaSDevelopment and evaluation of tri-functional immunoliposomes for the treatment of HER2 positive breast cancerPharm Res20183559510.1007/s11095-018-2365-x29536232
   PubMedGoogle Scholar
• MussiSVSilvaRCOliveiraMCLucciCMAzevedoRBFerreiraLANew approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticlesEur J Pharm Sci2013481–228229010.1016/j.ejps.2012.10.02523178339
   PubMed Web of Science ®Google Scholar
• ZuYHuYYuXJiangSDocetaxel-loaded bovine serum albumin nanoparticles conjugated docosahexaenoic acid for inhibiting lung cancer metastasis to boneAnticancer Agents Med Chem201717454255110.2174/187152061666616081714365627539313
   PubMed Web of Science ®Google Scholar
• TrédanOGalmariniCMPatelKTannockIFDrug resistance and the solid tumor microenvironmentJ Natl Cancer Inst200799191441145410.1093/jnci/djm13517895480
   PubMed Web of Science ®Google Scholar
• PrimeauAJRendonAHedleyDLilgeLTannockIFThe distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumorsClin Cancer Res20051124 Pt 18782878810.1158/1078-0432.CCR-05-166416361566
   PubMed Web of Science ®Google Scholar
• Johnson-ArborKDubeyRStatPearls [Internet]Treasure Island (FL)StatPearls Publishing2017 2018
   Google Scholar
• SubediRKKangKWChoiHKPreparation and characterization of solid lipid nanoparticles loaded with doxorubicinEur J Pharm Sci2009373–450851310.1016/j.ejps.2009.04.00819406231
   PubMed Web of Science ®Google Scholar
• LiYWangJWientjesMGAuJLDelivery of nanomedicines to extracellular and intracellular compartments of a solid tumorAdv Drug Deliv Rev2012641293910.1016/j.addr.2011.04.00621569804
   PubMed Web of Science ®Google Scholar
• MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEur J Pharm Biopharm200971340941910.1016/j.ejpb.2008.11.01019070661
   PubMed Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113510.1016/j.addr.2010.03.01120304019
   PubMed Web of Science ®Google Scholar
• ZhangYSunTJiangCBiomacromolecules as carriers in drug delivery and tissue engineeringActa Pharm Sin B201881345010.1016/j.apsb.2017.11.00529872621
   PubMed Web of Science ®Google Scholar
• AlkenSKellyCMBenefit risk assessment and update on the use of docetaxel in the management of breast cancerCancer Manag Res2013535736510.2147/CMAR.S4932124143122
   PubMedGoogle Scholar
• HeXWangJLiYEfficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trialsOnco Targets Ther201582023203110.2147/OTT.S8564826346649
   PubMed Web of Science ®Google Scholar
• HennenfentKLGovindanRNovel formulations of taxanes: a review. Old wine in a new bottle?Ann Oncol200617573574910.1093/annonc/mdj10016364960
   PubMed Web of Science ®Google Scholar
• LiSQinJTianCThe targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapyOncotarget20145113622363510.18632/oncotarget.196925004114
   PubMedGoogle Scholar
• ZhangJYeEWangJVariations of cellular membrane phospholipids with genesis of gastric cancerMod Oncol20101808550857
   Google Scholar
• StubbsCDSmithADThe modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and functionBiochim Biophys Acta19847791891376229284
   PubMedGoogle Scholar
• MarienEMeisterMMuleyTNon-small cell lung cancer is characterized by dramatic changes in phospholipid profilesInt J Cancer201513771539154810.1002/ijc.2951725784292
   PubMed Web of Science ®Google Scholar
• WolffACDonehowerRCCarducciMKPhase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profileClin Cancer Res2003910 Pt 13589359714506145
   PubMed Web of Science ®Google Scholar
• FracassoPMPicusJWildiJDPhase 1 and pharmacokinetic study of weekly docosahexaenoic acid paclitaxel, Taxoprexin, in resistant solid tumor malignanciesCancer Chemother Pharmacol200963345145810.1007/s00280-008-0756-018414864
   PubMedGoogle Scholar
• PayneMEllisPDunlopDDHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II openlabel multicenter trialJ Thorac Oncol20061998499017409983
   PubMedGoogle Scholar
• HomsiJBedikianAYKimKBPhase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patientsMelanoma Res200919423824210.1097/CMR.0b013e32832a1e2f19521262
   PubMedGoogle Scholar
• BedikianAYDe ContiRCConryRPhase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanomaAnn Oncol201122478779310.1093/annonc/mdq43820855467
   PubMed Web of Science ®Google Scholar
• HomsiJBedikianAYPapadopoulosNEPhase 2 open-label study of weekly docosahexaenoic acid paclitaxel in patients with metastatic uveal melanomaMelanoma Res201020650751010.1097/CMR.0b013e3283403ce920881508
   PubMed Web of Science ®Google Scholar
• AhmadGEl SaddaRBotchkinaGOjimaIEganJAmijiMNanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growthCancer Lett2017406718010.1016/j.canlet.2017.08.00428803993
   PubMed Web of Science ®Google Scholar
• AhmadGGattaceccaFEl SaddaRBiodistribution and phar-macokinetic evaluations of a novel taxoid DHA-SBT-1214 in an oil-in-water nanoemulsion formulation in naïve and tumor-bearing micePharm Res20183549110.1007/s11095-018-2349-x29520477
   PubMedGoogle Scholar
• VredenburgMROjimaIVeithJEffects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistanceJ Natl Cancer Inst200193161234124511504769
   PubMedGoogle Scholar
• Marín-AguileraMCodony-ServatJKalkoSGIdentification of docetaxel resistance genes in castration-resistant prostate cancerMol Cancer Ther201211232933910.1158/1535-7163.MCT-11-028922027694
   PubMed Web of Science ®Google Scholar
• CassanoRMellaceSMarrelliMConfortiFTrombinoSα-Tocopheryl linolenate solid lipid nanoparticles for the encapsulation, protection, and release of the omega-3 polyunsaturated fatty acid: in vitro anti-melanoma activity evaluationColloids Surf B Biointerfaces201715112813310.1016/j.colsurfb.2016.11.04327988473
   PubMedGoogle Scholar
• SeriniSCassanoRCorsettoPARizzoAMCalvielloGTrombinoSOmega-3 PUFA loaded in resveratrol-based solid lipid nanoparticles: physicochemical properties and antineoplastic activities in human colorectal cancer cells in vitroInt J Mol Sci2018192E58610.3390/ijms1902058629462928
   PubMed Web of Science ®Google Scholar
• ReyaTMorrisonSJClarkeMFWeissmanILStem cells, cancer, and cancer stem cellsNature2001414685910511110.1038/3510216711689955
   PubMed Web of Science ®Google Scholar
• WichaMSLiuSDontuGCancer stem cells: an old idea – a paradigm shiftCancer Res20066641883189010.1158/0008-5472.CAN-05-315316488983
   PubMed Web of Science ®Google Scholar
• ClarkeMFFullerMStem cells and cancer: two faces of eveCell200612461111111510.1016/j.cell.2006.03.01116564000
   PubMed Web of Science ®Google Scholar
• CalvielloGSeriniSPiccioniEn-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involvedCurr Med Chem200714293059306918220742
   PubMedGoogle Scholar
• FasanoESeriniSPiccioniEDHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell linesBiochim Biophys Acta20121822111762177210.1016/j.bbadis.2012.08.00322898250
   PubMedGoogle Scholar
• SeriniSOttes VasconcelosRFasanoECalvielloGEpigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 polyunsaturated fatty acid targets in colon inflammation and cancerExpert Opin Ther Targets201620784385810.1517/14728222.2016.113908526781478
   PubMed Web of Science ®Google Scholar
• SeriniSFasanoEPiccioniEDHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β-catenin nuclear translocationCarcinogenesis201233116417310.1093/carcin/bgr24022045024
   PubMedGoogle Scholar
• SeriniSFasanoECellenoLCittadiniACalvielloGPotential of long-chain n-3 polyunsaturated fatty acids in melanoma preventionNutr Rev201472425526610.1111/nure.1209324665956
   PubMedGoogle Scholar
• SeriniSZinziAOttes VasconcelosRRole of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cellsJ Dermatol Sci201684214915910.1016/j.jdermsci.2016.06.01027600927
   PubMedGoogle Scholar
• MensinkRPEffects of stearic acid on plasma lipid and lipoproteins in humansLipids200540121201120516477803
   PubMed Web of Science ®Google Scholar
• CroweFLAllenNEApplebyPNFatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European prospective investigation into cancer and nutritionAm J Clin Nutr20088851353136310.3945/ajcn.2008.2636918996872
   PubMedGoogle Scholar
• LiuYZWuKHuangJThe PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferationInt J Oncol201445110411210.3892/ijo.2014.239224756222
   PubMed Web of Science ®Google Scholar
• BraskyTMDarkeAKSongXPlasma phospholipid fatty acids and prostate cancer risk in the SELECT trialJ Natl Cancer Inst2013105151132114110.1093/jnci/djt17423843441
   PubMed Web of Science ®Google Scholar
• HullMASandellACMontgomeryAAA randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trialTrials20131423710.1186/1745-6215-14-5923895505
   PubMedGoogle Scholar
• PiazziGD’ArgenioGProssomaritiAEicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiotaInt J Cancer201413592004201310.1002/ijc.2885324676631
   PubMedGoogle Scholar
• NakanishiMHanleyMPZhaRA novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in ApcΔ14/+ miceCarcinogenesis201839342943810.1093/carcin/bgx13629206907
   PubMedGoogle Scholar
• RoseDPConnollyJMOmega-3 fatty acids as cancer chemopreventive agentsPharmacol Ther199983321724410576293
   PubMed Web of Science ®Google Scholar
• RoynetteCECalderPCDupertuisYMPichardCn-3 polyunsaturated fatty acids and colon cancer preventionClin Nutr200423213915110.1016/j.clnu.2003.07.00515030953
   PubMed Web of Science ®Google Scholar
• DupertuisYMMeguidMMPichardCColon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acidsCurr Opin Clin Nutr Metab Care200710442743210.1097/MCO.0b013e3281e2c9d417563460
   PubMedGoogle Scholar
• LeeJYSimTBLeeJENaHKChemopreventive and chemotherapeutic effects of fish oil derived omega-3 polyunsaturated fatty acids on colon carcinogenesisClin Nutr Res20176314716010.7762/cnr.2017.6.3.14728770178
   PubMedGoogle Scholar
• NoriegaBSSanchez-GonzalezMASalyakinaDCoffmanJUnderstanding the impact of omega-3 rich diet on the gut microbiotaCase Rep Med20162016308930310.1155/2016/389830727065349
   PubMedGoogle Scholar
• NappiABerrettaMRomanoCMetastatic colorectal cancer: role of target therapies and future perspectivesCurr Cancer Drug Targets201818542142910.2174/15680096176661702009514328183254
   PubMed Web of Science ®Google Scholar
• NikpoorARTavakkol-AfshariJSadriKJalaliSAJaafariMRImproved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: in vitro and in vivo studiesNanomedicine20171382671268210.1016/j.nano.2017.08.01028847682
   PubMed Web of Science ®Google Scholar
• CoutzacCAdamJSoularueEColon immune-related adverse events: anti-CTLA-4 and anti-PD-1 blockade induce distinct immunopathological entitiesJ Crohns Colitis201711101238124610.1093/ecco-jcc/jjx08128967957
   PubMed Web of Science ®Google Scholar
• ZárateREl Jaber-VazdekisNTejeraNPérezJARodríguezCSignificance of long chain polyunsaturated fatty acids in human healthClin Transl Med2017612510.1186/s40169-017-0153-628752333
   PubMedGoogle Scholar
• BowenKJHarrisWSKris-EthertonPMOmega-3 fatty acids and cardiovascular disease: are there benefits?Curr Treat Options Cardiovasc Med201618116910.1007/s11936-016-0487-127747477
   PubMedGoogle Scholar
• MansonJECookNRLeeIMMarine n-3 fatty acids and prevention of cardiovascular disease and cancerN Engl J Med20193801233210.1056/NEJMoa181140330415637
   PubMed Web of Science ®Google Scholar
• SeriniSCalvielloGLong-chain omega-3 fatty acids and cancer: any cause for concern?Curr Opin Clin Nutr Metab Care2018212838910.1097/MCO.000000000000043929232261
   PubMedGoogle Scholar
• BhattDLStegPGMillerMCardiovascular risk reduction with icosapent ethyl for hypertriglyceridemiaN Engl J Med20193801112210.1056/NEJMoa181279230415628
   PubMed Web of Science ®Google Scholar
• MozaffarianDWuJHOmega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical eventsJ Am Coll Cardiol2011582047206710.1016/j.jacc.2011.06.06322051327
   PubMed Web of Science ®Google Scholar
• HarrisWSvon SchackyCThe omega-3 index: a new risk factor for death from coronary heart disease?Prev Med200439121222010.1016/j.ypmed.2004.02.03015208005
   PubMed Web of Science ®Google Scholar
• FasanoESeriniSCittadiniACalvielloGLong-chain n-3 PUFA against breast and prostate cancer: which are the appropriate doses for intervention studies in animals and humans?Crit Rev Food Sci Nutr201757112245226210.1080/10408398.2013.85006025897862
   PubMed Web of Science ®Google Scholar
• AungTHalseyJKromhoutDAssociations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individualsJAMA Cardiol2018322523410.1001/jamacardio.2017.520529387889
   PubMed Web of Science ®Google Scholar
• ZhangYFGaoHFHouAJZhouYHEffect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trialsBMC Public Health20141420410.1186/1471-2458-14-20424568238
   PubMedGoogle Scholar
• AntiMArmelaoFMarraGEffects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomasGastroenterology19941076170917187958682
   PubMed Web of Science ®Google Scholar
• BougnouxPHajjajiNFerrassonMNGiraudeauBCouetCLe FlochOImproving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trialBr J Cancer2009101121978198510.1038/sj.bjc.660544119920822
   PubMed Web of Science ®Google Scholar
• WestNJClarkSKPhillipsRKEicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposisGut201059791892510.1136/gut.2009.20064220348368
   PubMed Web of Science ®Google Scholar
• DyerbergJBangHOHaemostatic function and platelet polyunsaturated fatty acids in EskimosLancet1979243343589498
   PubMed Web of Science ®Google Scholar
• BragaMLjungqvistOSoetersPFearonKWeimannABozzettiFESPEN Guidelines on Parenteral Nutrition: SurgeryClin Nutr20092837838619464088
   PubMed Web of Science ®Google Scholar
• JeansenSWitkampRFGarthoffJAvan HelvoortACalderPCFish oil LC-PUFAs do not affect blood coagulation parameters and bleeding manifestations: analysis of 8 clinical studies with selected patient groups on omega-3-enriched medical nutritionClin Nutr20183794895710.1016/j.clnu.2017.03.02728427779
   PubMedGoogle Scholar
• D’EliseoDVelottiFOmega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapyJ Clin Med201652E1510.3390/jcm502001526821053
   PubMedGoogle Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50310.1016/S1470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• PawelecGGoldeckDDerhovanessianEInflammation, ageing and chronic diseaseCurr Opin Immunol201429232810.1016/j.coi.2014.03.00724762450
   PubMed Web of Science ®Google Scholar
• IlagLLAre long-chain polyunsaturated fatty acids the link between the immune system and the microbiome towards modulating cancer?Medicines (Basel)201853E10210.3390/medicines503010230201858
   PubMedGoogle Scholar
• LiangPHenningSMSchokrpurSEffect of dietary omega-3 fatty acids on tumor-associated macrophages and Prostate Cancer ProgressionProstate201676141293130210.1002/pros.2321827338236
   PubMedGoogle Scholar
• GevariyaNBesançonMRobitailleKOmega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated miceProstate201979192010.1002/pros.2370630073695
   PubMedGoogle Scholar
• KhadgeSSharpJGMcGuireTRImmune regulation and anti-cancer activity by lipid inflammatory mediatorsInt Immunopharmacol20186558059210.1016/j.intimp.2018.10.02630447537
   PubMed Web of Science ®Google Scholar
• GuesdonWKosarajuRBrophyPEffects of fish oils on ex vivo B-cell responses of obese subjects upon BCR/TLR stimulation: A pilot studyJ Nutr Biochem201853728010.1016/j.jnutbio.2017.10.00929195133
   PubMedGoogle Scholar
• HouTYMcMurrayDNChapkinRSOmega-3 fatty acids, lipid rafts, and T cell signalingEur J Pharmacol20167852910.1016/j.ejphar.2015.03.09126001374
   PubMedGoogle Scholar
• WachtelNRohwerNPietznerALoewAWeylandtKHOmega-3 fatty acid supplementation-a possible dietary adjunct to enhance immune therapy in cancer?J Cell Biotech201814[1–2]8388
   Google Scholar
• CostantiniLMolinariRFarinonBMerendinoNImpact of omega-3 fatty acids on the gut microbiotaInt J Mol Sci20171812E264510.3390/ijms1812264529215589
   PubMed Web of Science ®Google Scholar
• HondaKLittmanDRThe microbiota in adaptive immune homeostasis and diseaseNature2016535758410.1038/nature1884827383982
   PubMed Web of Science ®Google Scholar
• SanzYDe PalmaGGut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue functionInt Rev Immunol20092839741310.3109/0883018090321561319954356
   PubMed Web of Science ®Google Scholar